Skip to Main Content

Molecular Therapeutics Shared Resource

The Molecular Therapeutics Shared Resource (MTSR) at Sylvester provides preclinical drug discovery and development capabilities with the goal of discovering novel small molecules that have the potential to become drugs for the treatment of cancer. Nearly all human-directed research is aimed at understanding disease with the goal of finding cures. The most powerful and efficient way to treat disease is by use of pharmaceuticals. The MTSR provides expertise in drug discovery to begin the process of uncovering novel treatments for cancer.

Services offered by the MTSR include assay development, compound screening, in vitro models, library curation & preparation and other work related to the preclinical drug discovery pipeline, including customized assays, target validation and full pipeline project management. MTSR services, which include cell death assays, clonogenic assays, alphascreen, plate reading and library addition, enable translation of basic research to clinical utility. The MTSR validates therapeutically relevant targets, identified in Sylvester members’ research, to support the advancement clinical research.

The MTSR is located within the seventh floor of the Biomedical Research Building (BRB), a modern 72,000 square foot building that opened in 2009. To request consultation and services, investigators can contact the MTSR via phone or email.

 

Contact us

 

Shaun P. Brothers, Ph.D., Director

Email: sbrothers@miami.edu

 

Phone

305-243-6113

 

 

Mailing Address

Biomedical Research Building

1501 NW 10th Avenue

M860 7th Floor

Miami, FL 33136

 

 

Physical Address

Biomedical Research Building

1501 NW 10th Avenue

M860 7th Floor

Miami, FL 33136